Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leef BrandsLEEEF +1.35%30 Equity-to-Asset is -0.14 as of Mar. 2026. GuruFocus rates LEEEF with a GF Score™ of 30/100 and a GF Value™ of $0.12 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Leef Brands ranks worse than 93.05% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Leef Brands's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $-5.75 Mil. Leef Brands's Total Assets for the quarter that ended in Mar. 2026 was $41.85 Mil.
Therefore, Leef Brands's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was -0.14.
The historical rank and industry rank for Leef Brands's Equity-to-Asset or its related term are showing as below:
LEEEF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -291 Med: 0.4 Max: 0.99
Current: -0.14
During the past 13 years, the highest Equity to Asset Ratio of Leef Brands was 0.99. The lowest was -291.00. And the median was 0.40.
LEEEF's Equity-to-Asset is ranked worse than 93.05% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs LEEEF: -0.14
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Leef Brands Equity-to-Asset Related Terms
Leef Brands Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Leef Brands's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Leef Brands's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leef Brands Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Leef Brands's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Leef Brands's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Leef Brands's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leef Brands (LEEEF) has a Equity-to-Asset of -0.14 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Leef Brands and its competitors. According to the industry distribution chart, Leef Brands ranks #937 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 93%.
Is Leef Brands' Equity-to-Asset too high?
Leef Brands' current Equity-to-Asset is -0.14. Based on the distribution chart, Leef Brands ranks #937 out of 1007 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Leef Brands has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leef Brands' Equity-to-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Leef Brands ranks #937 out of 1007 companies for Equity-to-Asset. This places Leef Brands in the lower half of its industry. The industry median Equity-to-Asset is 0.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Leef Brands and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leef Brands's current Equity-to-Asset is -0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leef Brands stock overvalued right now?
Based on GuruFocus' analysis, Leef Brands (LEEEF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.12, compared to a current price of $0.19 — trading 59.7% above its estimated fair value. The current Equity-to-Asset is -0.14. Leef Brands' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Leef Brands (LEEEF), the current Equity-to-Asset is -0.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leef Brands (LEEEF) Overvalued in 2026?
Based on GuruFocus' analysis, Leef Brands stock appears to be overvalued.
The current stock price of $0.19 is trading 59.7% above its estimated GF Value™ of $0.12.
GuruFocus considers Leef Brands to be Significantly Overvalued.
Key valuation signals for LEEEF:
Equity-to-Asset: -0.14
GF Value™: $0.12 vs. price of $0.19 (59.7% above fair value)
No single metric tells the full story. See the LEEEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Leef Brands Inc is a vertically integrated cannabis extraction and manufacturing operator based in California. The company operates in two reportable segments: Wholesale concentrates and Retail. The wholesale concentrate segment includes the propagation, nursery, flowering canopy, drying, processing, manufacturing and distribution of cannabis concentrates. The retail segment includes company owned and operated retail cannabis store in the state of California. It derives majority of the revenue from Wholesale concentrates segment.
30GF Score
Get the complete analysis for LEEEF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEEEF has been successfully added to your 
